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ABSTRACT
CCancer is an automatically collected database of
gene lists, which were reported mostly by experi-
mental studies in various biological and clinical
contexts. At the moment, the database covers
3369 gene lists extracted from 2644 papers pub-
lished in 80 peer-reviewed journals. As input,
CCancer accepts a gene list. An enrichment
analyses is implemented to generate, as output, a
highly informative survey over recently published
studies that report gene lists, which significantly
intersect with the query gene list. A report on gene
pairs from the input list which were frequently
reported together by other biological studies is
also provided. CCancer is freely available at
http://mips.helmholtz-muenchen.de/proj/ccancer.
INTRODUCTION
At the moment, various high-throughput experimental
platforms are employed intensively to provide new
insights into the molecular mechanisms underlying a
variety of biological phenomena (1,2). An increasing
number of biological or clinical studies report diﬀerential-
ly expressed genes, epigenetically silenced genes, frequent-
ly mutated genes, genes with copy number variations or
other gene lists involved in common biological processes.
Although being publicly available, this type of informa-
tion, at the same time, is dissolved in hundreds of papers.
The only way to collect this valuable data is to use auto-
matic text mining systems.
Text-mining systems are employed by biomedical re-
searchers to automatically extract relevant information
from the literature [see ref. (3) for a review]. For
example, PolySearch (4) is a generic text mining system
for extracting relationships between genes and diseases.
Several other databases, which are based on text mining,
focus on specialized research areas: PubMeth (5) and
MeInfoText (6) collect information on gene methylation
in cancer. DDOC (7) and DDEC (8) collect heterogeneous
information about genes diﬀerentially expressed in
ovarian and esophageal cancer, such as manually
curated information about the promoter regions and
associated transcription factors, as well as text-mined
reports.
Recently, we have developed the PLIPS database, a col-
lection of protein lists extracted from proteomics studies
by text-mining (9). PLIPS also provides a statistical frame-
work for the interpretation of a protein list. To generate
the PLIPS database, relatively few ‘text mining’ eﬀorts
were required, since a majority of proteomics studies are
published in a few highly specialized proteomics journals.
PLIPS covers only ﬁve major proteomics journals
(Proteomics, Journal of Proteome Research, Molecular
and Cellular Proteomics, Proteomics—Clinical
Applications) and 1000 diﬀerent protein lists extracted
from 800 independent studies.
In contrast to proteomics, high-throughput genomic
technologies were more frequently used and their results
are published in a much wider spectrum of journals. Gene
lists, which were characterized to play key roles in molecu-
lar mechanisms for a variety of biological phenomena, are
regularly reported in general biological journals, as well as
in highly speciﬁc medical journals. Thus, automatic ex-
traction of this information requires a lot of additional
eﬀorts.
Here, we present a database, termed CCancer, which
provides a collection of 3369 gene lists automatically
extracted from tables in 2644 studies covering 80
peer-reviewed journals. Cancer is a major focus of bio-
medical research. According to our estimates, more than
a half of the gene lists stored in CCancer are extracted
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of the database.
CCancer is not only a database but a web-based
analysis platform, which employs an enrichment
analyses framework (10–14) to interpret a given
user-deﬁned gene list. As input, CCancer accepts gene/
protein list. As output, a catalogue of previously published
studies that report a table of genes/proteins, which signiﬁ-
cantly intersects with a query list, is provided. Thus, CCa
ncer supports the interpretation of the functional context
for an experimentally derived gene lists. To illustrate the
valuable and often unprecedented information that the
user can get by using the CCancer database, we present
several examples of data analyses.
MATERIALS AND METHODS
Text mining
We collected all articles (150000) published in 80
peer-reviewed journals for the last 5–7 years. The articles
were screened for tables which report gene identiﬁers. The
search algorithm was implemented to recognize a table
with gene/protein identiﬁers within the paper text. If the
table reports at least 10 unique gene identiﬁers of the same
type [i.e. ‘Entrez Gene IDs’, ‘Gene Symbols’, ‘RefSeq’,
‘UNIGENE’, ‘ENSEMBL’, ‘Aﬀymetrix Probes’,
‘IPISYN (Internatinal Protein Identiﬁre)’, ‘Uniprot,
SwissProt’] then the paper was selected. In total 3369
gene/protein lists were identiﬁed from 2644 papers. All
gene list were mapped to ‘Entrez Gene IDs’. The data in
Ccancer covers 20000 unique ‘Entrez Gene IDs’.
The top journals, in terms of the number of extracted
gene lists, were highly speciﬁc journals in cancer research:
‘Cancer Research’ (327 papers and 411 gene lists),
‘Oncogene’ (214 papers and 278 gene lists), ‘Clinical
Cancer Research’ (149 papers and 178 gene list),
‘International Journal of Cancer’ (109 papers and
143 gene lists). The full list of journals is accessible on
the web server (http://mips.helmholtz-muenchen.de/proj/
ccancer/journals).
We would like to point out that the data were collected
automatically. A gene list in the database may be incom-
plete (in comparison to the originally reported list in the
paper) and might have false positive gene identiﬁers. In
our estimate based on 100 randomly selected records,
60% of records are of high quality (the original table
in the paper and the Ccancer record have <10% of false
negative and false positive genes), 20% of records are of
good quality (containing 10–25% false negatives and not
more than 10% of false positives) and 15% of records
contains 35–75% of genes actually reported in the paper
table. About 3–5% of the records may represent artefacts,
i.e. a result from a wrongly recognized table which does
not actually reports a gene list.
Automatic annotation of gene lists with human disease
terms
A comprehensive hierarchical controlled vocabulary for
human disease (http://do-wiki.nubic.northwestern.edu/
index.php/Main_Page) was used to link articles to
human disease terms. First we computed the background
distribution for each disease term using all available
articles (150000). For each disease term ‘A’ we select
the subset of articles where the term was present at least
once and compute for each article from this subset the
number of times the term ‘A’ was present in the paper.
The average number of times the term ‘A’ was mentioned
per paper across this subset was computed. If a term ‘A’
was mentioned twice as many times as computed average
value, then the paper was annotated with term ‘A’.
The gene lists from Ccancer database were annotated
with ‘human disease terms’ based on the annotation of the
paper from which it was extracted. We would like to point
out that the biological context of genes reported in the
table may not correspond to the context of the terms
overrepresented in the paper text. In each case, manual
analysis is required.
Statistical analysis: intersection of gene lists
To statistically link a given gene list (the query list) to the
lists from the database we implement standard enrichment
analyses. For each gene/protein list L in the database, the
number of genes I common between the query list and the
gene list L are counted. The null hypothesis H0 ‘Genes
from the query list (size NQ) and from the list L (size
NL) have at least I common genes by chance’ is tested.
The hypergeometric test, adjusted for multiple testing by
a Monte–Carlo simulation procedure, is employed
to assess the signiﬁcance of the intersection I. The
estimated P-value corresponds exactly to the deﬁnition
of an experiment-wise Westfall and Young P-value
(11,12,15–17).
Statistical analysis: signiﬁcantly associated gene pairs
Based on the data from the Ccancer database we identiﬁed
gene pairs which were signiﬁcantly associated (frequently
reported together). Let us denote N as the total number of
tables in the Ccancer database. Let us denote Cj to be the
number of tables from Ccancer database where gene j was
reported. For each pair of genes (j and k) we compute Cjk
the number of tables where both gene j and k were
reported. The number (intersection) Cjk follows a
hypergeometric distribution with parameters N, Cj and
Ck (‘Cj’ balls were drawn without replacement from an
urn containing ‘N’ balls in total, ‘Ck’ of which are
white). A Monte–Carlo simulation procedure was
employed to adjust the P-value for multiple testing (for
each gene we tested K hypotheses where K is a total
number of genes). At the signiﬁcance level (P<0.05)
each gene from the Ccancer database was associated on
average with 20 other genes.
Cross-linking of gene lists from the database
Extracted gene/protein lists were mapped to NCBI Entrez
Gene IDs. Each gene/protein list L in the database was
considered as ‘query’ list to identify the other lists from the
database which have signiﬁcant number of common genes
(with ‘query’ list). Thus, we cross-linked all gene list pairs
if they share a signiﬁcant number (P<0.01) of common
genes. This information can be browsed online
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Linking gene lists to gene ontology terms
Each gene/protein list from CCancer database was linked
to gene ontology (GO) terms which were signiﬁcantly
(P<0.01) enriched in the list (13). In analogy to the cal-
culation of the intersection P-value, a hypergeometric test,
adjusted for multiple testing using a Monte–Carlo simu-
lation approach, was employed to estimate the statistical
signiﬁcance of a GO category.
Monte–Carlo simulation to adjust P-values for multiple
testing
All three considered cases (intersection between gene list
and Ccancer records, GO enrichment of gene list and sig-
niﬁcantly associated gene pairs) can be modelled by the
same statistical model ‘sampling without replacement’. In
this model, k balls were drawn without replacement from
an urn containing ‘N’ balls in total, n of which are white
(all others are black). In this case, the number k1 of white
balls drawn from the urn follows a hypergeometric distri-
bution with parameters N, k and n. However, in our cases
the balls are multicolored and we actually test multiple
hypotheses at the same time: ‘white balls were drawn
randomly’, ‘blue balls were drawn randomly’, ‘red balls
were drawn randomly’ and so on. As we select the most
enriched whatever color (let say red for this case), the
estimated P-value based on the hypergeometric distribu-
tion does not reﬂect the actual probability to get k1o f
whatever color balls; it reﬂects the probability to get k1
red balls. To get the actual probability to get k1 whatever
color balls we need to adjust P-value for multiple testing.
One way to do this is to use Monte–Carlo simulation to
directly measure this probability based on, let say 1000
simulations.
In this case we simulate a random drawing of k balls
1000 times and each time we estimate the P-value based on
hypergeometric distribution for the best (whatever) color.
Thus, we got a distribution of size 1000 of the best
P-values for a random drawn of k balls and compare it
to the P-value for the best (whatever) color balls related to
our original drawn of k balls. The estimate of the adjusted
P-value is given by the share of random simulations where
the best P-value was equal or superior (less) than the
P-value for the best (whatever) color balls related to our
original drawing of k balls.
RESULTS
CCancer: interpretation of gene list
The user can query his/her list of gene/protein identiﬁers
to ﬁnd statistically signiﬁcant links to previously published
studies as well as to identify gene pairs from the submitted
list which were frequently reported together (P<0.05). As
input, CCancer accepts several types of gene identiﬁers.
CCancer supports most gene and protein identiﬁers such
as ‘Gene Symbol’, ‘Entrez Gene Id’, ‘UniProt/Swiss-Prot’,
‘UniGene’, ‘Ensembl’, ‘RefSeq Protein ID’, ‘RefSeq
Transcript ID’ and’Aﬀymetrix probe codes’. As output,
a catalogue of previously published studies that report a
table of genes that signiﬁcantly intersect with a query list is
provided.
After a list of potential studies is generated, one needs
to check manually all interesting hits. First, a list of gene
IDs common between query and database list need to be
checked (a link ‘Mapping protocol’ is provided on the
resulting page). Additionally, by looking into the corres-
ponding study (a link is provided on the resulting page)
one can understand better the functional context of the
‘database’ gene list. As been already mentioned in ‘text
mining’ section, the database was collected automatically
and, thus, some hits may represent artefacts.
CCancer: browsing for gene lists with common
biological properties
CCancer also provides an interface to browse gene lists
from the database with a common property. At the
moment, the user can select gene lists which are statistic-
ally linked to either a particular GO biological process
(http://mips.helmholtz-muenchen.de/proj/ccancer/go_bp),
molecular function (http://mips.helmholtz-muenchen.de/
proj/ccancer/go_mf) or cellular component (http://mips.
helmholtz-muenchen.de/proj/ccancer/go_cc). The possi-
bility to browse gene lists based on their local properties
is going to be extended in the future.
CCancer: examples of possible applications
Next we present examples of analyses of experimental data
by CCancer to illustrate the potential utility of our
database. In principle, interpretation of gene list using
CCancer is based on the widely accepted guilt-by-
association principle: signiﬁcant similarities between
protein lists can be indicative of similarity in molecular
mechanisms between corresponding phenomena. The
next example aims to illustrate this application of CCancer
Example 1: Relationship between the senescence phenotype
and cancer. A study by Young et al. (18) provided
evidence that autophagy-related genes mediate the acqui-
sition of the senescence phenotype. The authors studied 53
autophagy- and senescence-related genes, which were up-
or down-regulated after Ras induction. A screen in CCa
ncer for studies, which report gene sets that signiﬁcantly
intersect with the genes reported in ref. (18), identiﬁed
several related papers (P<0.01, Table 1). For example,
a study is detected, where Staber et al. (19) report genes
associated with recurrent acute myeloid leukemia after
high-dose chemotherapy. The genes, which were diﬀeren-
tially expressed in patients with acute myeloid leukemia
prior to high-dose chemotherapy and after relapse, signiﬁ-
cantly intersect with the senescence-related genes reported
by ref. (18).
Two other studies detected by CCancer covered related
topics. A study (21) described genes related to macrophage
activation and TH1 immune response, which were induced
by low-dose radiation therapy in follicular lymphoma. A
second study of ref. (22) identiﬁed genes diﬀerentially
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P-value lf Size of
query list
Size of
database list
Mapping
protocol
Study ‘Table number’, the number and type
of the protein/gene recognized, the title of
the article
Human disease ontology terms
over-represented in the article text
0.01 8 54 27 »Map Table 3, 25 UNIGENE_1 in epithelial and
stromal Cathepsin K and CXCL14 ex-
pression in breast tumour progression
Carcinoma in situ, breast cancer, radial
scar, breast tumor, ductal carcinoma,
cancer, carcinoma, scar
0.01 8 54 33 »Map Table 3, 33 REFSEQ_RNA_NAV in eﬀects
of imatinib on monocyte-derived dendrit-
ic cells are mediated by inhibition of
nuclear factor-{kappa}B and Akt
signalling pathways
Chronic myeloid leukemia, myeloid
leukemia, leukemia
0.01 5 54 30 »Map Table 1, 32 synonyms in identiﬁcation of
491 proteins in the tear ﬂuid proteome
reveals a large number of proteases and
protease inhibitors
Tear, disease
0.01 5 54 45 »Map Table 2, 40 synonyms in in vivo p53
response and immune reaction underlie
highly eﬀective low-dose radiotherapy in
follicular lymphoma
Follicular lymphoma, disease, lymphoma
0.01 7 54 99 »Map Table 1, 86 synonyms in gene expression
analysis of prostate hyperplasia in mice
overexpressing the prolactin gene speciﬁc-
ally in the prostate
Benign prostatic hyperplasia, intraepithelial
neoplasia, dna fragmentation,
hyperplastic, hyperplasia, cancer
0.01 4 54 41 »Map Table 1, 41 REFSEQ_RNA_NAV in
cytoglobin, the newest member of the
globin family, functions as a tumor sup-
pressor gene
Breast cancer, cancer
0.015 4 54 44 »Map Table 2, 44 REFSEQ_RNA_NAV in
common alterations in gene expression
and increased proliferation in recurrent
acute myeloid leukemia
Acute myeloid leukemia, myeloid leukemia,
leukemia, disease
0.015 5 54 75 »Map Table 1, 72 synonyms in identiﬁcation of
epigenetically silenced genes in tumor
endothelial cells
Cancer
0.015 5 54 75 »Map Table 2, 60 synonyms in molecular signa-
tures of self-renewal, diﬀerentiation, and
lineage choice in multipotential hemopoi-
etic progenitor cells in vitro
Nephroblastoma
0.015 6 54 114 »Map Table 1, 95 synonyms in knowledge-based
gene expression classiﬁcation via matrix
factorization
Disease
0.015 5 54 84 »Map Table 3, 73 synonyms in genetic expression
proﬁles and biologic pathway alterations
in head and neck squamous cell
carcinoma
Squamous cell carcinoma, neck cancer, oral
cancer, squamous carcinoma, cancer,
disease, carcinoma
0.015 4 54 74 »Map Table 1, 74 REFSEQ_RNA_NAV in dlk1/
FA1 regulates the function of human
bone marrow mesenchymal stem cells by
modulating gene expression of
pro-inﬂammatory cytokines and immune
response-related factors
0.015 4 54 77 »Map Table 1, 67 SYNONYMS in Comparative
analysis of genes regulated by PML/RAR
(20) and PLZF/RAR (20) in response to
retinoic acid using oligonucleotide arrays
Leukemia
0.015 4 54 78 »Map Table 2, 67 UNIGENE_1 in genetic expres-
sion proﬁles and biologic pathway alter-
ations in head and neck squamous cell
carcinoma
Squamous cell carcinoma, neck cancer, oral
cancer, squamous carcinoma, cancer,
disease, carcinoma
0.015 4 54 85 »Map Table 1, 76 synonyms in genomic and
proteomic analysis of the myeloid diﬀer-
entiation program
Leukemia
0.015 4 54 93 »Map Table 3, 83 synonyms in diﬀerentiation of
lung adenocarcinoma, pleural mesotheli-
oma, and nonmalignant pulmonary
tissues using DNA methylation proﬁles
Lung adenocarcinoma, malignant mesotheli-
oma, pleural mesothelioma, cancer,
adenocarcinoma, adenocarcinomas, meso-
thelioma, confusion
0.015 6 54 227 »Map Table 3, 190 synonyms in inﬂammatory
manifestations of experimental lymphatic
insuﬃciency’
Retinoblastoma, disease, lymphedema
(continued)
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lymphoblastoid cells.
A relationship between cancer- and senescence-related
genes or pathways would have been certainly expected.
Interestingly, some topics, which emerged form the com-
parison of senescence-related genes to the studies in the
CCancer database, were related to cancer therapy or prog-
nosis. For instance, the studies commonly reported
Cathepsin B and D (CTSB/D) and Cathepsin L1
(CTSL1), which participate in protein degradation and
turnover (23,24).
Another output from Ccancer (Table 2) reports pairs of
genes which were frequently reported together. For
example, the already mentioned genes Cathepsin L1
(CTSL1) and Cathepsin B and D (CTSB/D) were
reported together much more frequently than it would
be expected by chance. CTSL1 and CTSB were reported
together by 12 Ccancer records while each gene was
reported 78 and 49 times, respectively (P<0.05).
Interesting, 7 out of 12 papers were related to ‘cancer’
and three to ‘LEUKEMIA’.
Example 2: Searching for novel potential clinical
applications of drugs. CCancer can further be exploited
to identify hints for novel clinical applications of known
drugs (25) or drugs under development in the case, where
the list of drug molecular targets is known. For a variety
of cell disorders (including most cancer subtypes) CCancer
stores lists of genes identiﬁed to be at diﬀerential states
(comparison between normal versus disordered cells). This
type of information can be mined to identify new potential
therapeutic implications. Signiﬁcant number of common
genes between drug targets and gene lists from the
database related to some cell disorder can be indicative
of probable usability of the drug for the corresponding
disease.
For example, Bosutinib is a novel promiscuous kinase
inhibitor. We extracted a reported list of direct interactors
of Bosutinib identiﬁed by chemical proteomics (26). We
used CCancer to identify previously reported gene lists
that have a signiﬁcantly share of common genes/proteins
(http://mips.helmholtz-muenchen.de/proj/ccancer/example
.html) and, thus, to identify potential physiological condi-
tions, where an application of Bosutinib might be eﬀective.
Among already known applications, like diﬀerent types of
‘leukemia’ (27,28), CCancer suggests other speciﬁc cancer
types, like ‘oral squamous cell carcinoma’(28).
DISCUSSION
Here, we have generated a comprehensive collection of
gene list reported by the papers in 80 peer-reviewed
journals. Tables in articles usually present, to some
extent, pre-processed gene lists, which are selected for sig-
niﬁcance by experts. To our knowledge, no existing
text-mining system provides a similarly accessible and
comparable collection of experimentally derived gene
lists for analysis.
Table 1. Continued
P-value lf Size of
query list
Size of
database list
Mapping
protocol
Study ‘Table number’, the number and type
of the protein/gene recognized, the title of
the article
Human disease ontology terms
over-represented in the article text
0.015 4 54 106 »Map Table 1, 92 synonyms in overexpression of
the Axl tyrosine kinase receptor in cuta-
neous SCC-derived cell lines and tumors
Skin cancer, cancer, carcinoma
0.025 7 54 360 »Map Table W2, 433 AFFY in chromosomal in-
stability is associated with higher expres-
sion of genes implicated in
epithelial-mesenchymal transition, cancer
invasiveness, and metastasis and with
lower expression of genes involved in cell
cycle checkpoints, DNA repair, and chro-
matin maintenance
Squamous cell carcinoma, neoplastic trans-
formation, leukemia, cancer, lipoma
0.025 5 54 206 »Map Table 2, 179 synonyms in sequential gene
expression changes in cancer cell lines
after treatment with the demethylation
agent 5-Aza-2-deoxycytidine
Cancer, carcinoma, hepatoma
0.025 4 54 137 »Map Table 1, 119 synonyms in transcriptional
response of lymphoblastoid cells to
ionizing radiation—genome research
DNA damage
lf: number of genes in the intersection.
Table 2. An example of a CCancer output: a query list of
autophagy- and senescence-related genes
Gene ID Associated
gene
The number
of times
reported
together
Disease terms,
associated with gene pair
CTSL1 CTSB 12 (78,49) Leukemia (3) cancer (7)
carcinoma (3)
CTSL1 CTSS 5 (49,29) Cancer (3) carcinoma (2)
CTSL1 CTSD 9 (66,49) Leukemia (4) cancer (3) disease (3)
myeloid leukemia (2)
CTSL1 CTSA 5 (49,20) Leukemia (2) cancer (3)
Gene pairs frequently reported together (a part of the table).
W122 Nucleic Acids Research, 2010,Vol.38, Web Server issueThe CCancer database provides a computational inter-
face, which generates a highly informative survey over
recently published cancer-related studies, which report
similar and signiﬁcantly intersecting gene lists. As we
have demonstrated, by applying this automatic analysis,
the user may obtain sometimes unexpected links to
previous studies. It would be a tedious, if not impossible
task for experimental researchers to gain these insights by
a manual analysis of the literature. Articles, which contain
signiﬁcantly intersecting gene lists, are not necessarily
listed as ‘related articles’ in PubMed. In addition, CCa
ncer implements a robust statistical treatment of the inter-
section between a query and a database gene list, and
provides a valid estimate of the P-values by a Monte–
Carlo simulation procedure. The P-values actually reﬂect
the probability of getting an intersection of the same size,
in terms of the number of genes, for any random query
gene list.
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